Page last updated: 2024-08-23

amikacin and Pulmonary Consumption

amikacin has been researched along with Pulmonary Consumption in 44 studies

Research

Studies (44)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (13.64)	18.7374
1990's	6 (13.64)	18.2507
2000's	9 (20.45)	29.6817
2010's	19 (43.18)	24.3611
2020's	4 (9.09)	2.80

Authors

Authors	Studies
Chaplin, M; Davies, GR; De Vos, M; Pillay, S; Schumacher, SG; Steingart, KR; Theron, G; Warren, R	1
Gao, M; Guo, Y; Huo, F; Jia, J; Jiang, H; Li, W; Ma, H; Qin, L; Wu, X; Xue, Y; Yin, J; Zhu, C	1
Daley, CL; Griffith, DE	1
Bate, PNN; Chiwala, G; Fang, C; Guan, P; Hameed, HMA; Hu, J; Khan, SA; Liu, J; Liu, Z; Mugweru, JN; Tan, S; Tan, Y; Wang, B; Yusuf, B; Zhang, T; Zhong, N	1
Al-Hajoj, S; Varghese, B	1
Frota, SMMC; Kritski, AL; Ruffino-Netto, A; Vasconcelos, KA	1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M	1
Abdi, H; Arube, P; Dlamini, MG; Joloba, ML; Kamulegeya, R; Kasule, GW; Katabazi, FA; Kateete, DP; Khumalo, D; Kigozi, E; Lukoye, D; Musisi, K; Sebit, SI	1
Carter, ER; Iwanaga, K	1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S	1
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP	1
Bhattacharyya, D; Brewer, CC; Fleshner, M; Folio, LR; Glaser, TS; Holland, SM; Olivier, KN; Park, IK; Prevots, DR; Sampaio, EP; Shallom, S; Shaw, PA; Siegelman, JR; Zalewski, CK; Zelazny, AM	1
Böttger, EC; Freihofer, P; Lenaerts, A; Meyer, M; Scherman, M; Teague, J	1
de Droogh, E; Groenen, G; Mathys, V; Soetaert, K; van de Vyvere, M	1
Bender, WS; Egan, JP; Mukherjee, V	1
Bouchaud, O; Figoni, J; Gousseff, M; Leblanc, C; Méchaï, F; Vignier, N	1
Forsman, LD; Hoffner, S; Hu, Y; Mansjö, M; Werngren, J; Xu, B; Zheng, R; Zheng, X	1
Gunasekaran, J; Shariff, M	1
Gumbo, T; Magazi, BT; Modongo, C; Pasipanodya, JG; Sirugo, G; Srivastava, S; Williams, SM; Zetola, NM	1
Blackmore, T; McNaughton, A; McNaughton, H	1
Cho, SY; Kang, HY; Kim, CK; Kim, YJ; Lee, HJ; Oh, TS	1
Amiri, M; Baghaei, P; Caminero, JA; Chitsaz, E; Farnia, P; Kazempour, M; Mansouri, D; Marjani, M; Masjedi, MR; Shamaei, M; Tabarsi, P; Velayati, AA	1
Banavaliker, JN; Behera, D; Bhatnagar, AK; Hanif, M; Kaushik, A; Makkar, N; Pande, JN; Porwal, C; Singh, UB; Singla, R	1
Baba, T; Ikehara, K; Ishigatsubo, Y; Kaneko, T; Kusano, N; Nishiyama, H; Shinohara, T; Shoji, A; Suzuki, S; Tagawa, A; Tsuburai, T	1
Kam, KM; Yip, CW	1
Carbonell, D; Fernández-Olivera, N; García-García, I; López-Saura, PA; Machado-Molina, D; Milanés-Virelles, MT; Suárez-Méndez, R; Valdés-Quintana, M; Valenzuela-Silva, CM	1
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V	1
Kamio, Y; Kimura, S; Kuriu, K; Nakajima, H; Shibuya, Y; Shikama, Y	1
Ovsiankina, ES; Panova, LV	1
Allan, WG; Allen, BW; Chan, YC; Girling, DJ; Mitchison, DA; Yew, WW	1
Ciccolo, F; Lacchini, C; Miradoli, A; Penati, V; Sabolla, L	1
Cacciatore, R; Hartwig, C; Sanders, WE; Schneider, N; Valdez, H	1
Fudenberg, HH; Harley, RA; John, JF; Metcalf, JF; Wilson, GB	1
Michałowska-Mitczuk, D	1
Bhagat, R; Panchal, N; Shah, A	1
Coker, RJ; Fisher, M; Tomlinson, DR	1
Björkholm, M; Engervall, P; Kalin, M	1
Chen, M; Qian, H; Zhang, Y	1
Bartsch, P; Corhay, JL; Gach, O; Lousberg, L	1
Donald, PR; Mitchison, DA; Parkin, DP; Sirgel, FA; Smit, E; Van de Wal, BW; Venter, A	2
Levchenko, AE	1
Hayashi, I; Kaishio, K; Kawamorida, K; Konno, K; Kudo, S; Kurita, K; Nagai, K; Oizumi, K; Watanabe, A	1
Aleksandrova, AE; Boldina, IG; Vinogradova, TI; Vishnevskiĭ, BI	1

Reviews

4 review(s) available for amikacin and Pulmonary Consumption

Article	Year
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. The Cochrane database of systematic reviews, 2022, 05-18, Volume: 5 Topics: Adult; Amikacin; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2022
Treatment of Mycobacterium abscessus Pulmonary Disease. Chest, 2022, Volume: 161, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Disease Management; Drug Resistance, Bacterial; Humans; Macrolides; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary	2022
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150 Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
[Patients with chronic sputum positive tuberculosis-a therapeutic problem]. Pneumonologia i alergologia polska, 1995, Volume: 63, Issue:1-2 Topics: Amikacin; Amoxicillin; Antitubercular Agents; Chronic Disease; Clarithromycin; Clofazimine; Humans; Rifabutin; Sputum; Tuberculosis, Pulmonary	1995

Trials

3 trial(s) available for amikacin and Pulmonary Consumption

Article	Year
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study. BMC infectious diseases, 2004, Oct-22, Volume: 4 Topics: Adjuvants, Immunologic; Adult; Amikacin; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Interferon-gamma; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Pilot Projects; Pyrazinamide; Radiography; Recombinant Proteins; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2004
[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1997, Volume: 20, Issue:6 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoscopy; Catheterization, Peripheral; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1997
The early bactericidal activity of amikacin in pulmonary tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2001, Volume: 5, Issue:6 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Colony Count, Microbial; Drug Monitoring; Female; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Sputum; Time Factors; Tuberculosis, Pulmonary	2001

Other Studies

37 other study(ies) available for amikacin and Pulmonary Consumption

Article	Year
Case report: A 9-year systematic treatment failure of a pulmonary tuberculosis patient. Frontiers in public health, 2022, Volume: 10 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Treatment Failure; Tuberculosis, Pulmonary	2022
A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line anti-tuberculosis regimen. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021, Volume: 142 Topics: Amikacin; Animals; Antigens, Bacterial; Antitubercular Agents; BCG Vaccine; Disease Models, Animal; Drug Resistance, Bacterial; Levofloxacin; Mice, Inbred BALB C; Mice, SCID; Mycobacterium bovis; Mycobacterium tuberculosis; Plasmids; Prothionamide; Pyrazinamide; Tuberculosis, Pulmonary; Vaccines, Synthetic; Virulence	2021
First Insight Into the Fluoroquinolone and Aminoglycoside Resistance of Multidrug-Resistant The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5 Topics: Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Genes, Bacterial; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Risk Factors; Saudi Arabia; Tandem Repeat Sequences; Tuberculosis, Pulmonary	2017
Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2018, Volume: 44, Issue:2 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Audiometry, Pure-Tone; Auditory Threshold; Early Diagnosis; Female; Hearing; Hearing Disorders; Hearing Tests; Humans; Longitudinal Studies; Male; Middle Aged; Otoacoustic Emissions, Spontaneous; Prospective Studies; Reproducibility of Results; Statistics as Topic; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2018
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016). BMC pulmonary medicine, 2019, Jul-10, Volume: 19, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Eswatini; Fluoroquinolones; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sequence Analysis, DNA; Somalia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uganda	2019
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy. Pediatric pulmonology, 2014, Volume: 49, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Child, Preschool; Clarithromycin; Female; Humans; Laryngostenosis; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline; Tomography, X-Ray Computed; Tracheostomy; Tuberculosis, Pulmonary	2014
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease. Annals of the American Thoracic Society, 2014, Volume: 11, Issue:1 Topics: Administration, Inhalation; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bronchiectasis; Cystic Fibrosis; Female; Humans; Kartagener Syndrome; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Pulmonary	2014
In vivo efficacy of apramycin in murine infection models. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:11 Topics: Amikacin; Animals; Anti-Bacterial Agents; Female; Interferon-gamma; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Knockout; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nebramycin; Neutropenia; Staphylococcal Infections; Tuberculosis, Pulmonary	2014
False-positive rifampicin resistance on Xpert® MTB/RIF caused by a silent mutation in the rpoB gene. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:10 Topics: Aged; Amikacin; Amino Acid Sequence; Antibiotics, Antitubercular; Bacterial Proteins; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Fluoroquinolones; Genotype; Humans; Isoniazid; Male; Molecular Sequence Data; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Phenotype; Pyrazinamide; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Pulmonary	2014
Inhaled Antibiotics for Refractory Nontuberculous Mycobacteria and Non-Cystic Fibrosis Bronchiectasis and the Significance of Mycobacterium abscessus subsp. abscessus Isolation during M. avium Complex Lung Disease Therapy. American journal of respiratory and critical care medicine, 2015, 07-01, Volume: 192, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Female; Humans; Male; Mycobacterium Infections, Nontuberculous; Tuberculosis, Pulmonary	2015
Active pulmonary tuberculosis: Role for amikacin in early treatment. Medecine et maladies infectieuses, 2016, Volume: 46, Issue:6 Topics: Adult; Amikacin; Antitubercular Agents; Bacterial Load; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Patient Isolation; Sputum; Time Factors; Tuberculosis, Pulmonary	2016
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; China; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2016
Pulmonary Nocardiosis: Review of Cases and an Update. Canadian respiratory journal, 2016, Volume: 2016 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cough; Diabetes Mellitus; Dyspnea; Female; Humans; Imipenem; Immunocompromised Host; India; Male; Meropenem; Middle Aged; Nocardia Infections; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary	2016
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Artificial Intelligence; Botswana; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Theoretical; Mycobacterium tuberculosis; Regression Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2016
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand. The European respiratory journal, 2016, Volume: 48, Issue:4 Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary	2016
RNA expression analysis of efflux pump genes in clinical isolates of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in South Korea. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2017, Volume: 49 Topics: Adenosine Triphosphatases; Amikacin; Antitubercular Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Expression; Genes, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sequence Analysis, DNA; Tuberculosis, Pulmonary	2017
Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran. Microbial drug resistance (Larchmont, N.Y.), 2010, Volume: 16, Issue:1 Topics: Adult; Amikacin; Anti-Bacterial Agents; Clinical Protocols; Cycloserine; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Prothionamide; Treatment Outcome; Tuberculosis, Pulmonary	2010
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region. PloS one, 2013, Volume: 8, Issue:2 Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Incidence; India; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary	2013
[A case of lung infection due to Mycobacterium abscessus]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2003, Volume: 41, Issue:8 Topics: Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Radiography; Sputum; Tuberculosis, Pulmonary	2003
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2004, Volume: 8, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2004
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2003
[A case of Mycobacterium abscessus pulmonary infection; effectiveness of clarithromycin, amikacin and imipenem/cilastatin]. Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2006, Volume: 44, Issue:11 Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography, Thoracic; Tuberculosis, Pulmonary	2006
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents]. Problemy tuberkuleza i boleznei legkikh, 2007, Issue:5 Topics: Adolescent; Amikacin; Antitubercular Agents; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2007
Amikacin in the treatment of pulmonary tuberculosis. Tubercle, 1983, Volume: 64, Issue:2 Topics: Adult; Amikacin; Capreomycin; Drug Resistance, Microbial; Female; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Pulmonary	1983
Anti-mycobacterial activity of amikacin. Bollettino dell'Istituto sieroterapico milanese, 1983, Nov-30, Volume: 62, Issue:5 Topics: Amikacin; Animals; Diabetes Mellitus, Type 1; Guinea Pigs; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Tuberculosis, Pulmonary	1983
Activity of amikacin against Mycobacteria in vitro and in murine tuberculosis. Tubercle, 1982, Volume: 63, Issue:3 Topics: Amikacin; Animals; Female; Isoniazid; Kanamycin; Mice; Mycobacterium; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Streptomycin; Tuberculosis, Pulmonary	1982
Mycobacterium fortuitum pulmonary infection associated with an antigen-selective defect in cellular immunity. The American journal of medicine, 1981, Volume: 71, Issue:3 Topics: Amikacin; Cell Migration Inhibition; Immunity, Cellular; Leukocyte Migration-Inhibitory Factors; Mycobacterium Infections, Nontuberculous; T-Lymphocytes; Tuberculosis, Pulmonary	1981
Resistant tuberculosis: successful treatment with amikacin, ofloxacin, clofazimine, and pas. Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 1993, Volume: 74, Issue:1 Topics: Adult; Amikacin; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Male; Ofloxacin; Tuberculosis, Pulmonary	1993
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1996
Disseminated tuberculosis treated with amikacin in a patient with acute myelocytic leukemia. Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:4 Topics: Abscess; Adrenal Gland Diseases; Aged; Amikacin; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Pulmonary	1997
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis]. Revue des maladies respiratoires, 1999, Volume: 16, Issue:5 Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breast Diseases; Bronchoscopy; Cesarean Section; Ciprofloxacin; Drug Therapy, Combination; Eclampsia; Ethambutol; Female; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1999
The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis. The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:6 Topics: Adult; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Confidence Intervals; Humans; Liposomes; Male; Regression Analysis; Serum Bactericidal Test; Tuberculosis, Pulmonary	2001
[Intensive therapy of patients with pulmonary tuberculosis]. Voenno-meditsinskii zhurnal, 2002, Volume: 323, Issue:5 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Bronchi; Drug Resistance, Bacterial; Drug Tolerance; Female; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Rifampin; Time Factors; Treatment Outcome; Tuberculosis, Pulmonary	2002
[Therapeutic effect of amikacin for infections with gram-negative bacilli, especially for stubborn respiratory infections (author's transl)]. The Japanese journal of antibiotics, 1978, Volume: 31, Issue:1 Topics: Adult; Aged; Amikacin; Bronchiectasis; Chronic Disease; Drug Evaluation; Empyema; Female; Humans; Kanamycin; Lung Neoplasms; Male; Middle Aged; Pneumonia; Respiratory Tract Infections; Tuberculosis, Pulmonary; Urinary Tract Infections	1978
[Anti-tuberculous activity of amikacin]. Problemy tuberkuleza, 1986, Issue:5 Topics: Amikacin; Animals; Antitubercular Agents; Drug Synergism; Drug Therapy, Combination; Kanamycin; Male; Mice; Tuberculosis, Pulmonary	1986